Safety Profile

• TWINZOL was evaluated for safety in 1035 patients with elevated IOP treated for open angle glaucoma or ocular hypertension, approximately 5% of all patients discontinued therapy due to some adverse reactions like:

• Taste perversion, ocular burning, conjunctival hyperemia, blurred vision, blepharitis & bronchitis.

• TWINZOL should be used with caution in patients with:

  • Respiratory & cardiac diseases.

  • Renal & hepatic impairment.

  • Severe disturbance of blood circulation in the extremeties.

  • Hypersensitivity to dorzolamide.
• It is contraindicated in the following:

• Reactive airway diseases including bronchial asthma or chronic obstructive pulmonary diseases.
• Bradycardia, 2nd or 3rd degree of atrioventricular block, cardiac failure & cardiogenic shock.
• Severe renal impairment.
• Hypersensitivity to any of the drug components.

Twinzol Overview
Twinzol Mechanism of Action
Twinzol Efficacy
Safety Profile
Frequently Asked Questions